4527.T
4527.T
JP3982400008
ROHTO PHARMACEUTICAL CO
Loading chart...

Company Profile

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.

Related stocks

4912.T
4912.T • Japan
LION CORP
1,768.5 JPY
3.09B USD 1Y +14.5%
4967.T
4967.T • Japan
KOBAYASHI PHARMACEUTICALS
7,238 JPY
3.4B USD 1Y +37.4%
1318.HK
1318.HK • China
MAO GEPING
46.5 HKD
2.9B USD 1Y -53.9%
4922.T
4922.T • Japan
KOSE HLDGS CORP
5,514 JPY
1.98B USD 1Y -5.5%
483650.KS
483650.KS • South Korea
d'Alba Global
175,000 KRW
1.62B USD 1Y +7.9%
4927.T
4927.T • Japan
POLA ORBIS HOLDINGS INC
1,380.5 JPY
1.93B USD 1Y +4%
7956.T
7956.T • Japan
PIGEON CORP
2,099 JPY
1.58B USD 1Y +18.8%
8283.T
8283.T • Japan
PALTAC CORP
6,630 JPY
2.54B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.5% p.a.
Max Drawdown (5Y)
-51.6%
Sharpe Ratio (5Y)
0.21
Beta Factor
-0.41
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -51.6% in the extended horizon.
ende